Search

Displaying results 8201 - 8210 of 10000 in total
  1. Drug

    Ioprocemic acid

    go.drugbank.com/drugs/DB20503
    Experimental

    Ioprocemic acid is a small molecule drug. Ioprocemic acid has a monoisotopic molecular weight of 612.81 Da.

  2. Drug

    Broxitalamic acid

    go.drugbank.com/drugs/DB20561
    Experimental

    Broxitalamic acid is a small molecule drug. Broxitalamic acid has a monoisotopic molecular weight of 499.82 Da.

  3. Drug

    Aceburic acid

    go.drugbank.com/drugs/DB20668
    Experimental

    Aceburic acid is a small molecule drug. Aceburic acid has a monoisotopic molecular weight of 146.06 Da.

    Synonyms: 4-hydroxybutyric acid acetate
  4. Drug

    Tibric acid

    go.drugbank.com/drugs/DB20908
    Experimental

    Tibric acid is a small molecule drug. Tibric acid has a monoisotopic molecular weight of 331.06 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Oxfendazole

    go.drugbank.com/drugs/DB11446
    InvestigationalVet approved

    Oxfendazole is a sulfoxide metabolite of fenbendazole. This benzimidazole antihelminthic protects livestock from roundworm. strongyles, and pinworn.

    Synonyms: Fenbendazole S-oxide, 5-phenylsulfinyl-2-carbomethoxyaminobenzimidazoleCategories: Heterocyclic Compounds, 2-Ring
  6. Drug

    DCFBC F-18

    go.drugbank.com/drugs/DB14772
    Investigational

    DCFBC F-18 is under investigation in clinical trial NCT02190279 (18F-DCFBC PET/CT in Prostate Cancer).

    Synonyms: DCFBC F-18
  7. Drug

    Procalcitonin

    go.drugbank.com/drugs/DB14812
    Investigational

    Procalcitonin is under investigation in clinical trial NCT03440060 (Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPD).

  8. Drug

    Modotuximab

    go.drugbank.com/drugs/DB14827
    Investigational

    Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).

  9. Drug

    Narnatumab

    go.drugbank.com/drugs/DB14964
    Investigational

    Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors).

  10. Drug

    MEDI-491

    go.drugbank.com/drugs/DB17859
    Experimental

    MEDI-491 is a recombinant human parvovirus B19 vaccine composed of the VP1 and VP2 capsid proteins.